Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 5:42 pm Purchase | 13G | VIVOS THERAPEUTICS INC VVOS | Huntsman Ronald Kirk | 94,794 4.3% | 94,794 (New Position) | View |
| 2024-02-14 3:57 pm Purchase | 13G | VIVOS THERAPEUTICS INC VVOS | ARMISTICE CAPITAL LLC | 175,099 9.99% | 175,099 (New Position) | View |
| 2023-02-10 4:05 pm Purchase | 13G | VIVOS THERAPEUTICS INC VVOS | Huntsman Ronald Kirk | 2,250,834 9% | 37,000 (+1.67%) | View |
| 2022-02-14 5:03 pm Purchase | 13G | VIVOS THERAPEUTICS INC VVOS | Huntsman Ronald Kirk | 2,213,834 9.62% | 130,000 (+6.24%) | View |
| 2022-02-14 5:02 pm Purchase | 13G | VIVOS THERAPEUTICS INC VVOS | Singh Gurdev Dave | 3,249,702 14.1% | 29,997 (+0.93%) | View |
| 2021-02-16 2:34 pm Purchase | 13G | VIVOS THERAPEUTICS INC VVOS | Singh Gurdev Dave | 3,219,705 17.7% | 3,219,705 (New Position) | View |
| 2021-02-16 2:32 pm Purchase | 13G | VIVOS THERAPEUTICS INC VVOS | Huntsman Ronald Kirk | 2,083,834 11.5% | 2,083,834 (New Position) | View |